Augmedix, Inc.
AUGX · NASDAQ
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | |
|---|---|---|---|---|
| Market Cap | $49,650 | $213,296 | $286,773 | $234,433 |
| - Cash | $28,220 | $37,426 | $46,342 | $22,286 |
| + Debt | $25,275 | $25,690 | $25,846 | $20,108 |
| Enterprise Value | $46,705 | $201,560 | $266,277 | $232,255 |
| Revenue | $13,664 | $13,471 | $12,680 | $11,767 |
| % Growth | 1.4% | 6.2% | 7.8% | – |
| Gross Profit | $6,455 | $6,341 | $6,246 | $5,830 |
| % Margin | 47.2% | 47.1% | 49.3% | 49.5% |
| EBITDA | -$7,309 | -$5,524 | -$3,564 | -$3,218 |
| % Margin | -53.5% | -41% | -28.1% | -27.3% |
| Net Income | -$8,450 | -$6,499 | -$4,491 | -$4,407 |
| % Margin | -61.8% | -48.2% | -35.4% | -37.5% |
| EPS Diluted | -0.16 | -0.12 | -0.092 | -0.097 |
| % Growth | -33.3% | -31% | 5.4% | – |
| Operating Cash Flow | -$3,889 | -$8,236 | -$973 | -$2,293 |
| Capital Expenditures | -$362 | -$568 | -$1,193 | -$437 |
| Free Cash Flow | -$4,251 | -$8,804 | -$2,166 | -$2,730 |